MicroPort NeuroTech (Shanghai) Co., Ltd.

MicroPort is a global medical technology company founded in 1998 in Shanghai, China, specializing in the development, manufacturing, and distribution of innovative medical devices across cardiovascular, orthopedic, and neurological therapeutic areas. The company has established a strong international presence with products available in over 90 countries and manufacturing facilities in China, the United States, France, and the United Kingdom. MicroPort's diverse portfolio includes coronary drug-eluting stents, implantable pacemakers (including MRI-compatible models), cardiac rhythm management solutions, reconstructive joint devices, and surgical robotics platforms. With over 4,500 employees and more than 3,000 issued patents, the company has achieved over 260 product approvals worldwide. MicroPort is committed to improving patient quality of life through advanced medical technology, with emphasis on clinical excellence, device miniaturization, and reliable supply chain management across hospital and interventional settings.